Täby, Sweden

Mathias Uhlen


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 1,392(Granted Patents)


Location History:

  • Täby, SE (2001)
  • Taby, SE (2005)

Company Filing History:


Years Active: 2001-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mathias Uhlen: Innovator in Polypeptide Selection

Introduction

Mathias Uhlen is a notable inventor based in Taby, Sweden. He has made significant contributions to the field of biotechnology, particularly in the selection and identification of polypeptides. His innovative methods have the potential to advance research and applications in various scientific domains.

Latest Patents

Mathias Uhlen holds a patent for a method titled "In vitro selection and optional identification of polypeptides using solid support carriers." This method involves the cell-free expression of nucleic acid molecules that are immobilized on a solid support system to produce desired polypeptides. The solid support system is designed for biospecific interaction with the desired polypeptide or a molecule attached to it. The process includes the separation of the solid support carrying both the desired polypeptide and the nucleic acid encoding it. Additionally, the method may involve the recovery of the nucleic acid and/or the desired polypeptide, along with molecular libraries for use in these methods. Mathias Uhlen has 1 patent to his name.

Career Highlights

Mathias Uhlen is associated with Affibody AB, a company that focuses on developing innovative biopharmaceuticals. His work at Affibody AB has allowed him to contribute to cutting-edge research and development in the field of biotechnology.

Collaborations

Mathias Uhlen has collaborated with notable colleagues, including Per-Ake Nygren and Olof Nord. These collaborations have further enhanced his research and innovation efforts in the biotechnology sector.

Conclusion

Mathias Uhlen is a distinguished inventor whose work in polypeptide selection has the potential to impact various scientific fields. His innovative methods and collaborations continue to drive advancements in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…